Injectable colloidal gold for use in intrafractional 2D image-guided radiation therapy
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Injectable colloidal gold for use in intrafractional 2D image-guided radiation therapy. / Jølck, Rasmus Irming; Rydhög, Jonas S.; Christensen, Anders Nymark; Hansen, Anders Elias; Bruun, Linda Maria; Schaarup-Jensen, Henrik; von Wenck, Asger; Børresen, Betina; Kristensen, Annemarie Thuri; Clausen, Mads Hartvig; Kjær, Andreas; Conradsen, Knut; Larsen, Rasmus; Munck af Rosenschöld, Per Martin; Andresen, Thomas L.
In: Advanced Healthcare Materials, Vol. 4, No. 6, 21.01.2015, p. 856-863.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Injectable colloidal gold for use in intrafractional 2D image-guided radiation therapy
AU - Jølck, Rasmus Irming
AU - Rydhög, Jonas S.
AU - Christensen, Anders Nymark
AU - Hansen, Anders Elias
AU - Bruun, Linda Maria
AU - Schaarup-Jensen, Henrik
AU - von Wenck, Asger
AU - Børresen, Betina
AU - Kristensen, Annemarie Thuri
AU - Clausen, Mads Hartvig
AU - Kjær, Andreas
AU - Conradsen, Knut
AU - Larsen, Rasmus
AU - Munck af Rosenschöld, Per Martin
AU - Andresen, Thomas L
N1 - © 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
PY - 2015/1/21
Y1 - 2015/1/21
N2 - In the western world, approximately 50% of all cancer patients receive radiotherapy alone or in combination with surgery or chemotherapy. Image-guided radiotherapy (IGRT) has in recent years been introduced to enhance precision of the delivery of radiation dose to tumor tissue. Fiducial markers are often inserted inside the tumor to improve IGRT precision and to enable monitoring of the tumor position during radiation therapy. In the present article, a liquid fiducial tissue marker is presented, which can be injected into tumor tissue using thin and flexible needles. The liquid fiducial has high radio-opacity, which allows for marker-based image guidance in 2D and 3D X-ray imaging during radiation therapy. This is achieved by surface-engineering gold nanoparticles to be highly compatible with a carbohydrate-based gelation matrix. The new fiducial marker is investigated in mice where they are highly biocompatible and stable after implantation. To investigate the clinical potential, a study is conducted in a canine cancer patient with spontaneous developed solid tumor in which the marker is successfully injected and used to align and image-guide radiation treatment of the canine patient. It is concluded that the new fiducial marker has highly interesting properties that warrant investigations in cancer patients.
AB - In the western world, approximately 50% of all cancer patients receive radiotherapy alone or in combination with surgery or chemotherapy. Image-guided radiotherapy (IGRT) has in recent years been introduced to enhance precision of the delivery of radiation dose to tumor tissue. Fiducial markers are often inserted inside the tumor to improve IGRT precision and to enable monitoring of the tumor position during radiation therapy. In the present article, a liquid fiducial tissue marker is presented, which can be injected into tumor tissue using thin and flexible needles. The liquid fiducial has high radio-opacity, which allows for marker-based image guidance in 2D and 3D X-ray imaging during radiation therapy. This is achieved by surface-engineering gold nanoparticles to be highly compatible with a carbohydrate-based gelation matrix. The new fiducial marker is investigated in mice where they are highly biocompatible and stable after implantation. To investigate the clinical potential, a study is conducted in a canine cancer patient with spontaneous developed solid tumor in which the marker is successfully injected and used to align and image-guide radiation treatment of the canine patient. It is concluded that the new fiducial marker has highly interesting properties that warrant investigations in cancer patients.
U2 - 10.1002/adhm.201400651
DO - 10.1002/adhm.201400651
M3 - Journal article
C2 - 25607532
VL - 4
SP - 856
EP - 863
JO - Advanced healthcare materials
JF - Advanced healthcare materials
SN - 2192-2640
IS - 6
ER -
ID: 132098354